Tachykinin receptors in the guinea-pig isolated bronchi

Eur J Pharmacol. 1991 May 17;197(2-3):167-74. doi: 10.1016/0014-2999(91)90517-t.

Abstract

The aim of the study was to assess which tachykinin receptors mediate the contractile response in the guinea-pig isolated bronchi. Experiments with natural tachykinins and receptor-selective tachykinin agonists were performed in the absence or presence of peptidase inhibitors and in bronchi pretreated with phenoxybenzamine. Both NK-1 (substance P, substance P methylester and septide) and NK-2 (neurokinin A, [beta-Ala8]neurokinin A-(4-10) and MDL 28,564) receptor agonists produced concentration-dependent contraction. NK-3 agonists (senktide and [MePhe7]neurokinin B) were active only at high concentrations. Phenoxybenzamine pretreatment reduced the maximal response to NK-1 agonists and produced a rightward shift of the curve to NK-2 agonists, without depression of the maximum. Five tachykinin antagonists selective for the NK-1 (L 668,169) or the NK-2 (MEN 10,207, MEN 10,376, L 659,877 and R 396) receptor were tested against substance P methylester and [beta-Ala8]neurokinin A-(4-10). The results indicated that these receptor-selective antagonists maintain their characteristic even when tested in a multireceptor assay such as the guinea-pig bronchus. The rank order of potency of NK-2 antagonists against [beta-Ala8]neurokinin A-(4-10) was MEN 10,207 = MEN 10,376 greater than L 659,877 much greater than R 396. This pattern, with the observation of the full agonist activity of MDL 28,564, indicates that in addition to NK-1 receptors, NK-2 receptors also are present in the guinea-pig bronchi and belong to the same subtype (NK-2A) as present in the rabbit pulmonary artery.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Bronchi / drug effects
  • Bronchi / metabolism*
  • Guinea Pigs
  • In Vitro Techniques
  • Male
  • Molecular Sequence Data
  • Neurokinin A / analogs & derivatives
  • Neurokinin A / chemistry
  • Neurokinin A / pharmacology
  • Oligopeptides / chemistry
  • Oligopeptides / pharmacology
  • Peptide Fragments / chemistry
  • Peptide Fragments / pharmacology
  • Phenoxybenzamine / pharmacology
  • Protease Inhibitors / pharmacology
  • Pyrrolidonecarboxylic Acid / analogs & derivatives
  • Receptors, Neurotransmitter / classification
  • Receptors, Neurotransmitter / drug effects
  • Receptors, Neurotransmitter / metabolism*
  • Receptors, Tachykinin
  • Substance P / analogs & derivatives
  • Substance P / chemistry
  • Substance P / pharmacology
  • Tachykinins / antagonists & inhibitors
  • Tachykinins / metabolism*

Substances

  • Oligopeptides
  • Peptide Fragments
  • Protease Inhibitors
  • Receptors, Neurotransmitter
  • Receptors, Tachykinin
  • Tachykinins
  • Phenoxybenzamine
  • neurokinin A (4-10), beta-Ala(8)-
  • Substance P
  • substance P, methyl ester-
  • septide
  • Neurokinin A
  • Pyrrolidonecarboxylic Acid